Changes in Serum Ceruloplasmin Levels Based on Immunomodulatory Treatments and Melatonin Supplementation in Multiple Sclerosis Patients

BACKGROUND: The cause of multiple sclerosis (MS) is currently unknown, but it is thought that oxidative damage and iron metabolism mechanisms are involved. The aim of this study was to examine ceruloplasmin concentration in MS patients based on various immunomodifying therapies and to test the effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Adamczyk-Sowa, Monika, Sowa, Paweł, Mucha, Sebastian, Zostawa, Jacek, Mazur, Bogdan, Owczarek, Maciej, Pierzchała, Krystyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2016
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958372/
https://www.ncbi.nlm.nih.gov/pubmed/27420299
http://dx.doi.org/10.12659/MSM.895702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958372/
https://www.ncbi.nlm.nih.gov/pubmed/27420299
http://dx.doi.org/10.12659/MSM.895702

Ejemplares similares